RIBOCICLIB PLUS EVEROLIMUS PHASE 0/2 CLINICAL TRIAL FOR RECURRENT GLIOBLASTOMAS. PIs: Nader Sanai, M.D., FAANS, FACS Director, Division of Neurosurgical Oncology Director, Barrow Brain Tumor Research Center Barrow Neurological InstituteZ NeuroTrials, LLC